Pulmonary hypertension often complicates heart failure hospitalizations, splitting into two main types: isolated postcapillary PH (IpcPH) and combined postcapillary and precapillary PH (CpcPH).
Guidelines updated these definitions in 2022, but doctors needed real data on how the changes affect predictions for patients admitted with heart failure. Researchers from the West Tokyo Heart Failure 2 registry examined 975 stable patients aged 69 years on average, with 33% women, who had right heart catheterization after their hospital stay. They grouped patients as NonPH, IpcPH, or CpcPH using both the 2018 and 2022 definitions, then tracked serious problems like cardiac death or heart failure readmission. The results were published in the Journal of Heart and Lung Transplant. 
Old Rules Saw Risk in Both PH Types
Under the 2018 definitions, both PH subtypes signaled higher trouble compared to no PH. Patients with CpcPH faced 62% greater odds of cardiac death or heart failure readmission (HR 1.62, 95% CI 1.14-2.31), while those with IpcPH showed 50% increased risk (HR 1.50, 95% CI 1.07-2.10). This suggested lung pressure issues from heart backup alone carried danger, matching earlier studies where any PH worsened outcomes. Clinicians relied on these splits to push diuretics, vasodilators, or closer monitoring during discharge planning.
New Rules Pin Danger on CpcPH Only
The 2022 update sharpened lines—CpcPH now requires higher precapillary resistance, cutting its group size from 19.8% to 34.8% of patients. Results shifted dramatically: only CpcPH independently raised adverse event risk by 75% (HR 1.75, 95% CI 1.30-2.36), while IpcPH lost significance (HR 1.03, 95% CI 0.64-1.65). Fewer patients fell into the risky CpcPH bucket, but those who did faced clearer threats. This refines who needs aggressive lung-heart fixes versus standard heart failure care.
Real Changes for Hospital Heart Teams
For decompensated patient with echo-estimated pulmonary hypertension, order right heart catheterization after clinical stabilization and apply the 2022 definitions for accurate subtyping. Combined postcapillary and precapillary PH (CpcPH) identifies high-risk patients at discharge, warranting home oxygen trials and early cardiology-pulmonology consultations. Isolated postcapillary PH (IpcPH) requires focus on guideline-directed medical therapy such as ARNI and SGLT2 inhibitors without specific PH-directed interventions.
Tailored Plans Save Lives Now
Guidelines evolve, and physicians can expect endorsements from the European Society of Cardiology or American Heart Association for the 2022 pulmonary hypertension definitions in the near future. For heart failure with preserved ejection fraction patient who has overlap with borderline pulmonary hypertension, consider rechecking right heart catheterization if combined postcapillary and precapillary PH remains possible. Precision medicine always outperforms blanket treatment approaches for these complex cases.